Our concept began when we measured a significant correlation between random errors and the reagents used in experiments. Curiosity led us beyond the bench to work on identifying a variety of contributing factors which included such issues as poor manufacturing standards, inconsistent data and supplier handling.
We determined that a large majority of these factors were avoidable, so we began building a repository of solutions to help minimize the risk of error.
Implementing these solutions into solid-phase and recombinant synthesis platforms has allowed us to re-introduce several gene/targets in their differing forms: ssDNA, RNA and Recombinant Protein. Powered by manufacturing seniority, these novel reagents follow the made-to-measure standards of kbDNA. A name inspired by the key contribution of kb ladders throughout our process.
We provide research laboratories in early-to-late phase discovery with synthetic bioreagents; ssDNA, RNA and Recombinant Proteins specific to their target objectives.